Bleakley Financial Group LLC Has $365,000 Stock Position in Doximity, Inc. (NASDAQ:DOCS)

Bleakley Financial Group LLC raised its holdings in Doximity, Inc. (NASDAQ:DOCS) by 39.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,839 shares of the company’s stock after purchasing an additional 1,943 shares during the quarter. Bleakley Financial Group LLC’s holdings in Doximity were worth $365,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of DOCS. Fountainhead AM LLC acquired a new stake in Doximity in the third quarter valued at about $710,000. Penserra Capital Management LLC bought a new position in shares of Doximity in the third quarter worth about $2,384,000. Los Angeles Capital Management LLC boosted its stake in shares of Doximity by 6,242.6% in the 3rd quarter. Los Angeles Capital Management LLC now owns 650,874 shares of the company’s stock valued at $28,359,000 after purchasing an additional 640,612 shares in the last quarter. Barclays PLC grew its holdings in shares of Doximity by 60.5% during the 3rd quarter. Barclays PLC now owns 53,401 shares of the company’s stock valued at $2,327,000 after purchasing an additional 20,125 shares during the last quarter. Finally, Oppenheimer & Co. Inc. increased its position in Doximity by 139.2% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 35,635 shares of the company’s stock worth $1,553,000 after purchasing an additional 20,740 shares in the last quarter. Institutional investors own 87.19% of the company’s stock.

Insider Activity

In related news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the transaction, the director now directly owns 6,360 shares of the company’s stock, valued at $366,463.20. The trade was a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 37.40% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on DOCS shares. Wells Fargo & Company increased their price target on Doximity from $43.00 to $55.00 and gave the company an “equal weight” rating in a research note on Friday, February 7th. Piper Sandler upgraded Doximity from a “neutral” rating to an “overweight” rating and increased their target price for the company from $31.00 to $78.00 in a research report on Friday, February 7th. Truist Financial boosted their price target on Doximity from $35.00 to $49.00 and gave the stock a “hold” rating in a report on Thursday, November 14th. The Goldman Sachs Group raised their price objective on shares of Doximity from $58.00 to $80.00 and gave the company a “neutral” rating in a report on Monday. Finally, Needham & Company LLC lifted their target price on shares of Doximity from $65.00 to $82.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $64.22.

Doximity Stock Down 9.9 %

Doximity stock opened at $74.91 on Wednesday. The firm has a fifty day simple moving average of $56.61 and a two-hundred day simple moving average of $46.63. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $85.21. The company has a market capitalization of $13.98 billion, a PE ratio of 74.91, a P/E/G ratio of 4.61 and a beta of 1.39.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.